BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 20804337)

  • 1. The morbidly adherent placenta: an overview of management options.
    Doumouchtsis SK; Arulkumaran S
    Acta Obstet Gynecol Scand; 2010 Sep; 89(9):1126-33. PubMed ID: 20804337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placenta previa, placenta accreta, and vasa previa.
    Oyelese Y; Smulian JC
    Obstet Gynecol; 2006 Apr; 107(4):927-41. PubMed ID: 16582134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The morbidly adherent placenta: diagnosis and management options.
    Hayes E; Ayida G; Crocker A
    Curr Opin Obstet Gynecol; 2011 Dec; 23(6):448-53. PubMed ID: 22002113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of interventional radiology in the management of morbidly adherent placenta.
    Rao AP; Bojahr H; Beski S; MacCallum PK; Renfrew I
    J Obstet Gynaecol; 2010; 30(7):687-9. PubMed ID: 20925610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Placenta accreta: screening, management and complications].
    Héquet D; Ricbourg A; Sebbag D; Rossignol M; Lubrano S; Barranger E
    Gynecol Obstet Fertil; 2013 Jan; 41(1):31-7. PubMed ID: 23291052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Standardized Approach for Transfusion Medicine Support in Patients With Morbidly Adherent Placenta.
    Panigrahi AK; Yeaton-Massey A; Bakhtary S; Andrews J; Lyell DJ; Butwick AJ; Goodnough LT
    Anesth Analg; 2017 Aug; 125(2):603-608. PubMed ID: 28640786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team.
    Erfani H; Fox KA; Clark SL; Rac M; Rocky Hui SK; Rezaei A; Aalipour S; Shamshirsaz AA; Nassr AA; Salmanian B; Stewart KA; Kravitz ES; Eppes C; Coburn M; Espinoza J; Teruya J; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2019 Oct; 221(4):337.e1-337.e5. PubMed ID: 31173748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Maternal morbidity and mortality associated with conservative management for placenta morbidly adherent (accreta) diagnosed during pregnancy. Report of 15 cases].
    Daney de Marcillac F; Lecointre L; Guillaume A; Sananes N; Fritz G; Viville B; Boudier E; Nisand I; Gaudineau A; Langer B; Akladios CY
    J Gynecol Obstet Biol Reprod (Paris); 2016 Oct; 45(8):849-858. PubMed ID: 27118678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anesthetic management of patients with placenta accreta and resuscitation strategies for associated massive hemorrhage.
    Snegovskikh D; Clebone A; Norwitz E
    Curr Opin Anaesthesiol; 2011 Jun; 24(3):274-81. PubMed ID: 21494133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidly adherent placenta previa in current practice: prediction and maternal morbidity in a series of 23 women who underwent hysterectomy.
    Alchalabi H; Lataifeh I; Obeidat B; Zayed F; Khader YS; Obeidat N
    J Matern Fetal Neonatal Med; 2014 Nov; 27(17):1734-7. PubMed ID: 24397837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of placenta accreta].
    Kayem G; Grangé G; Goffinet F
    Gynecol Obstet Fertil; 2007 Mar; 35(3):186-92. PubMed ID: 17317266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical and surgical treatment of placenta percreta to optimize bladder preservation.
    Lee PS; Bakelaar R; Fitpatrick CB; Ellestad SC; Havrilesky LJ; Alvarez Secord A
    Obstet Gynecol; 2008 Aug; 112(2 Pt 2):421-4. PubMed ID: 18669749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late complication due to placenta increta left in situ and management options.
    Zulfikir S; Al MB; Kakaria A; Gowri V; Saparamandu A; Al LK
    JNMA J Nepal Med Assoc; 2011; 51(184):196-8. PubMed ID: 22922901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conservative treatment of placenta accreta].
    Courbière B; Bretelle F; Porcu G; Gamerre M; Blanc B
    J Gynecol Obstet Biol Reprod (Paris); 2003 Oct; 32(6):549-54. PubMed ID: 14593301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and maternal outcome in morbidly adherent placenta.
    Sultana N; Mohyuddin S; Jabbar T
    J Ayub Med Coll Abbottabad; 2011; 23(2):93-6. PubMed ID: 24800353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal outcome after conservative management of abnormally invasive placenta.
    Su HW; Yi YC; Tseng JJ; Chen WC; Chen YF; Kung HF; Chou MM
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):353-357. PubMed ID: 28600047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormally invasive placenta: changing trends in diagnosis and management.
    Guleria K; Gupta B; Agarwal S; Suneja A; Vaid N; Jain S
    Acta Obstet Gynecol Scand; 2013 Apr; 92(4):461-4. PubMed ID: 23517217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of placenta accreta: to leave or remove the placenta?
    Perez-Delboy A; Wright JD
    BJOG; 2014 Jan; 121(2):163-9; discussion 169-70. PubMed ID: 24373590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative management of placenta previa-accreta by prophylactic uterine arteries ligation and uterine tamponade.
    Ferrazzani S; Guariglia L; Triunfo S; Caforio L; Caruso A
    Fetal Diagn Ther; 2009; 25(4):400-3. PubMed ID: 19786787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interest of modern imagery for conservative management of a placenta percreta].
    Bader G; Jelen H; Quarello E; Guyot B; Limot O; Ville Y
    Gynecol Obstet Fertil; 2007 Feb; 35(2):142-8. PubMed ID: 17223375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.